These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12670326)

  • 1. The efficacy of rHuEPO in cancer-related anaemia.
    Samol J; Littlewood TJ
    Br J Haematol; 2003 Apr; 121(1):3-11. PubMed ID: 12670326
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study.
    Tatarelli C; Piccioni AL; Maurillo L; Naso V; Battistini R; D'Andrea M; Criscuolo M; Nobile C; Villivà N; Mancini S; Neri B; Breccia M; Fenu S; Buccisano F; Voso MT; Latagliata R; Aloe Spiriti MA
    Ann Hematol; 2014 Aug; 93(8):1413-20. PubMed ID: 24647684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin and chronic lymphocytic leukemia.
    Mauro FR; Gentile M; Foa R
    Rev Clin Exp Hematol; 2002; Suppl 1():21-31. PubMed ID: 12735212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin in the treatment of anemic patients with hematological malignancies.
    Kasper C
    Ann Hematol; 2001 Jun; 80(6):319-29. PubMed ID: 11475144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The benefits of treatment with recombinant human erythropoietin in cancer patients].
    Solignac M;
    Presse Med; 2003 Sep; 32(29):1373-7. PubMed ID: 14534503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of recombinant human erythropoietin (rhuEPO) in treatment of anemia in patients with myelodysplastic syndrome].
    Wiecek A; Chudek J; Nieszporek T; Kokot F
    Pol Arch Med Wewn; 1992 Dec; 88(6):451-7. PubMed ID: 1300567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin therapy: need for rationality and active surveillance.
    Cazzola M
    Haematologica; 2003 Jun; 88(6):601-5. PubMed ID: 12801832
    [No Abstract]   [Full Text] [Related]  

  • 8. Management options for cancer therapy-related anaemia.
    Littlewood TJ
    Drug Saf; 2002; 25(7):525-35. PubMed ID: 12093310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A descriptive study of erythropoietin use and cost in hematologic patients].
    Pelufo Pellicer A; Monte Boquet E; Poveda Andrés JL; Cuéllar Monreal MJ
    Farm Hosp; 2006; 30(6):343-50. PubMed ID: 17298191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the clinical use and misuse of erythropoietin.
    Eagleton HJ; Littlewood TJ
    Curr Hematol Rep; 2003 Mar; 2(2):109-15. PubMed ID: 12901141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of erythropoietin in the treatment of patients with oncohematological diseases].
    Lysenko DA; Lutsenko OM
    Lik Sprava; 2005 Jun; (4):69-75. PubMed ID: 16158722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in anemia by recombinant human erythropoietin in patients with myelodysplastic syndrome and aplastic anemia.
    Hirashima K; Bessho M; Jinnai I
    Contrib Nephrol; 1991; 88():254-65. PubMed ID: 2040187
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors.
    Ludwig H; Fritz E; Leitgeb C; Krainer M; Kührer I; Sagaster P; Umek H
    Ann Oncol; 1993 Feb; 4(2):161-7. PubMed ID: 8448084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin for the treatment of anemia associated with hematological malignancy.
    Littlewood TJ
    Hematol Oncol; 2001 Mar; 19(1):19-30. PubMed ID: 11276043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human erythropoietin at high dose is effective for the treatment of the anemia of myelodysplastic syndromes.
    Laporte JP; Isnard F; Fenaux P; Woler M; Najman A
    Contrib Nephrol; 1991; 88():271-2; discussion 273-5. PubMed ID: 2040189
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of human recombinant erythropoietin in oncologic surgery].
    Mercuriali F
    Tumori; 1997; 83(4 Suppl 2):S16-9. PubMed ID: 9487379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pure red cell aplasia associated with recombinant erythropoietin: a case report and brief review of the literature.
    Mohd Slim MA; Shaik R
    N Z Med J; 2013 Nov; 126(1386):106-10. PubMed ID: 24316999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant erythropoietin in clinical practice.
    Ng T; Marx G; Littlewood T; Macdougall I
    Postgrad Med J; 2003 Jul; 79(933):367-76. PubMed ID: 12897214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of recombinant human erythropoietin to treat the anemia of myelodysplastic syndromes.
    Greenberg PL
    Semin Hematol; 1993 Oct; 30(4 Suppl 6):22-4. PubMed ID: 8153674
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythropoietin treatment for non-uremic patients: a personal view.
    Biesma DH
    Neth J Med; 1999 Jan; 54(1):10-5. PubMed ID: 10048290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.